A Phase 2b/3 clinical program for iDose TREX, its next-generationi Dose sustained-release procedural pharmaceutical platform therapy.
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Travoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- 21 Jan 2025 New trial record
- 14 Jan 2025 According to Glaukos media release, Glaukos has commenced this trial